Upgrade to SI Premium - Free Trial

FibroBiologics releases CYWC628 drug product for diabetic foot ulcer trial

May 4, 2026 8:30 AM
FibroBiologics Inc. (NASDAQ: FBLG) announced it has released the first batch of its CYWC628 drug product for use in a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

FDA